Abstract:Maternal and fetal plasma differ in their concentrations of the important drug binding plasma proteins, albumin and α1acid glycoprotein, with albumin being slightly more concentrated in fetal plasma, and α1-acid glycoprotein being only 37% of the maternal concentration at term. In general, these differences relate linearly to the bound to free concentration ratio of drugs associated with these proteins. Although only the free concentration is generally considered to be the pharmacologically active form, these differences can dramatically affect the total concentration and relative distribution of drugs between maternal and fetal plasma.In order to test our hypothesis that plasma protein binding is the major determinant of fetal/maternal drug distribution at steady-state, we examined whether fetal binding could be predicted from adult binding information. Data from studies of maternal, plasma protein binding were used to predict fetal plasma protein binding based solely on the differences in protein concentrations. These predictions were compared with observed fetal binding data. This analysis showed a slope near unity and a high correlation (r2 = 0.900) which implies that there are no significant differences between the binding affinities of these proteins. A similar analysis performed using data on drug binding in non-pregnant adults gave an r2 or 0.971.Having established that fetal plasma proteins bind drugs similarly to their maternal counterparts, fetal/maternal plasma drug concentration ratios (F/M) were predicted for various drugs using information from literature on the drug’s adult plasma protein binding, the protein to which it binds, and the fetal and maternal plasma concentrations of that binding protein. This information was compared with data from studies which observed the fetal/maternal plasma concentration ratio of these drugs at steady-state. The observed F/M ratio was correlated with the predicted F/M values for the 35 drugs (r2 = 0.473, p < 10−5. When considering only studies done at term the correlation coefficient increased to 0.558. This analysis was subject to the limitations of comparing mean data from different studies.The fact that nearly half or more of the variability of the transplacental drug concentration ratios at steady-state is explainable by the plasma protein concentration gradient, despite between-study variability, leads us to conclude that it is the most significant factor in establishing the F/M ratio at steady-state.

Molecular charge as a determinant of macromolecule permeability across the fetal capillary endothelium of the guinea-pig placenta

Ultrastructural study of endothelial permeability to macromolecules in fetal paraplacental capillaries of European badger

Size-dependent Placental Retention Effect of Liposomes in ICR Pregnant Mice: Potential Superiority in Placenta-Derived Disease Therapy

Expression and Distribution of Calcium-Binding Protein S100P in Human Placenta During Pregnancy

Intermembrane distances at the feto-maternal interface in epitheliochorial placentation

Expression of members of the multidrug resistance protein family in human term placenta

Physical and geometric determinants of transport in feto-placental microvascular networks

Absolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug Disposition

Placental folate transport during pregnancy

Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells

Modelling the maternal‐fetal interface: An in vitro approach to investigate nutrient and drug transport across the human placenta

Diffusion of macromolecules through sclera.

Organic Anion Transporting Polypeptide 2B1 in Human Fetal Membranes: A Novel Gatekeeper for Drug Transport During Pregnancy?

Proteome analysis of a plasma membrane-enriched fraction at the placental feto-maternal barrier

[PP.23.01] CULTURED TROPHOBLASTS ARE SALT-SENSITIVE WITH NA+ TRANSPORTERS DIFFERENTIALLY EXPRESSED IN PLACENTA OF PREGNANT RATS UPON PREGNANCY AND SALT EXPOSURE

The Significance of Plasma Protein Binding on the Fetal/Maternal Distribution of Drugs at Steady-State

Anomalous fractional clearance of negatively charged Ficoll relative to uncharged Ficoll

Age dependent contribution of entry via the CSF to the overall brain entry of small and large hydrophilic markers

Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size

Current understanding of placental fatty acid transport

Placental Transport of Amino Acids in Rats with Methionine-Induced Hyperhomocysteinemia